Evidence map›Paper›PMID 34113494›Full record

ArticleCureus2021

Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration.

Precious O Idogun, Mindy C Ward, Yeshanew Teklie, Wilhelmine Wiese-Rometsch, Joel Baker

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Precious O IdogunFlorida State University College of Medicine Internal Medicine Residency, Sarasota Memorial Hospital, Sarasota, USA.
Mindy C WardFlorida State University College of Medicine Internal Medicine Residency, Sarasota Memorial Hospital, Sarasota, USA.
Yeshanew TeklieFlorida State University College of Medicine Internal Medicine Residency, Sarasota Memorial Hospital, Sarasota, USA.
Wilhelmine Wiese-RometschFlorida State University College of Medicine Internal Medicine Residency, Sarasota Memorial Hospital, Sarasota, USA.
Joel BakerFlorida State University College of Medicine Internal Medicine Residency, Sarasota Memorial Hospital, Sarasota, USA.
Florida State University · USSarasota Memorial Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A few individuals are believed to have developed immune thrombocytopenia (ITP) following the administration of the coronavirus disease 2019 (COVID-19) vaccine. This phenomenon has been reported in a few case reports and also in some recent news articles. In this report, we discuss a case of a 54-year-old Caucasian female who presented to the emergency room with life-threatening thrombocytopenia in the setting of de novo ITP following COVID-19 vaccine administration. Due to the relapsing nature of ITP, it is unclear if the patient has achieved complete remission of the disease.

Indexed as

adverse eventcovid 19itpthrombocytopeniavaccination

Identifiers

PMID34113494
PMCPMC8176657
OpenAlexW3157465501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.